Hence then, the article about abelzeta presents preclinical data from study of c car168 for the treatment of autoimmune diseases at acr convergence 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024 )
Last updated :
Also on site :
- 2026 ASCO Abstract Highlights: Innovent Biologics' IBI363 (PD-1/IL-2α-bias bispecific fusion protein) Demonstrates Robust Survival Benefits in Long-Term Follow-up of PoC Study in Advanced Immunotherapy-Resistant Non-Small Cell Lung Cancer
- Javier Bardem, Mark Ruffalo, Walter Salles, Isabel Coixet, Annemarie Jacir & Yorgos Lanthimos Sign Anti-Bolloré Letter As Signatures Swell To 3.5K
- Who (Who Who) Is The Festive Owl? The Man Behind the Anonymous Festival News Channel Speaks